The Inflammation Panel 3 (cyno) Kit provides the assay-specific components for the quantitative determination of NGAL/lipocalin-2, tissue inhibitor of metalloproteinases (TIMP-1), and monocyte chemoattractant protein-1 (MCP-1) in cyno serum, plasma, and cell supernatant. Increased levels of these markers may play a pivotal role in the pathogenesis of inflammatory diseases such as atherosclerosis, rheumatoid arthritis, and acute kidney injury. TIMP-1 and NGAL/lipocalin-2 expression can indicate inflammatory action following infection, ischemia, and endotoxic insults to the endothelium and stromal matrix. MCP-1 is uniformly upregulated at sites of vascular disease or injury and is one of the earliest cellular responses to atherogenesis.